Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms

MT Newswires Live

01-17

Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.

Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.

Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.

Price: 165.26, Change: -8.65, Percent Change: -4.97

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2504946234"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2504946234\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2504946234?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-17 02:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2504946234","market":"nz","top_or_hot":-1,"title":"Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms","media":"MT Newswires Live","content":"<html><body><p> Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.</p><p>Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.</p><p>Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.</p><p>Price: 165.26, Change: -8.65, Percent Change: -4.97</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-17 02:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.</p><p>Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.</p><p>Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.</p><p>Price: 165.26, Change: -8.65, Percent Change: -4.97</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2504946234","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2504946234","pubTimestamp":1737052754,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Charles River Laboratories  and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.Price: 165.26, Change: -8.65, Percent Change: -4.97","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","CRL":"查尔斯河","BK4588":"碎股","BK4530":"医药外包概念","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK7095":"多种金属与采矿","BK4585":"ETF&股票定投概念","CRL.AU":"Comet Resources Ltd"},"translate_title":"Charles River Laboratories与Akron Bio合作改进癌症治疗平台","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1,"CRL.AU":1},"content_text":"Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.Price: 165.26, Change: -8.65, Percent Change: -4.97","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}